0010V0 — JPI Healthcare Co Income Statement
0.000.00%
- KR₩91bn
- KR₩70bn
- KR₩45bn
Annual income statement for JPI Healthcare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 45,412 | 45,053 |
| Cost of Revenue | ||
| Gross Profit | 19,151 | 19,615 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Total Operating Expenses | 38,842 | 41,115 |
| Operating Profit | 6,570 | 3,938 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 7,483 | 6,517 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 6,339 | 5,553 |
| Minority Interest | ||
| Net Income Before Extraordinary Items | ||
| Net Income | 6,608 | 6,036 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 6,608 | 6,036 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 1,303 | 1,183 |
| Dividends per Share |